Policy on partnership with commercial organisations.
NCUK understands the importance of working in partnership with all stakeholders with an interest in Neuroendocrine Cancer and related diseases to achieve common goals.
The pharmaceutical industry is a key stakeholder for NCUK and we wish to work in collaboration with different pharmaceutical companies. We recognise the need for such collaboration to be transparent and able to stand up to scrutiny. As a result, we have developed this policy document that defines how we engage with the pharmaceutical industry. This will ensure we can withstand external scrutiny of our decisions and actions whilst at the same time allowing us freedom to work in a way which ultimately benefits Neuroendocrine Cancer patients and their families.
Neuroendocrine Cancer UK is a UK wide charity solely dedicated to providing support and information to those affected by Neuroendocrine Cancer.
Subscribe to our Newsletter to stay update with our latest news.